S12 E01: The 2026 pharma forecast: Unknowns and personal goals

In Part 2 of the 2026 pharma forecast, the guests discuss the biggest unknowns for the year ahead and share a personal goal they're working towards in 2026. Speaker bios Dheepa Chari Vice President and Head of Global Scientific Communications, GSK Dheepa leads strategy and execution across oncology, vaccines, specialty care and general medicine, driving innovation in how scientific narratives are delivered. Emma Charles Senior Vice President of European Markets, BMS Emma oversees Bristol Myers Squibb's operations across 19 countries of Europe, bringing extensive global leadership experience spanning Europe, Asia, Latin America and the Middle East. Yacin Marzouki Omnichannel expert Within the pharmaceutical sector, Yacin specialises in shaping seamless customer journeys, driving content activation and aligning global strategies with local execution. Mary Stutts CEO, Healthcare Businesswomen's Association Mary leads a global organisation that advances representative leadership, strengthens the talent pipeline for healthcare and life sciences, and fuels business growth across the sector.

You can listen to S12 E01: The 2026 pharma forecast: Unknowns and personal goals online on Radio and Podcast. Open the player on this page to stream the available audio.

S12 E01: The 2026 pharma forecast: Unknowns and personal goals is an episode from The GOLD Podcast: Weekly Pharma Insights by Alice Watson.

This episode is 07:51 long.

This episode was published on Feb 19, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The GOLD Podcast: Weekly Pharma Insights when more episodes are available from the podcast feed.